[Primary gastric lymphoma. 14 clinical cases].
Fourteen patients affected by primary gastric lymphoma were observed retrospectively to verify the results of surgical and adjuvant chemotherapy. After a 85% preoperative diagnostic specificity, 79% of patients were subjected to surgical therapy by subtotal gastrectomy (93%) and by total gastrectomy (7%), and 64% of patients were subjected to adjuvant chemotherapy in conformity with CHOP and CVP. Classified by the Working formulation, 57% of cases presented a high grade of malignancy, 29% a low grade and 14% an intermediate grade. Classified by Ann Arbor with Mushoff's modification, 43% of patients were assigned to stage IIE1, 36% to stage IE, 14% to stage IIE2 and 7% to stage IIIE. Operative mortality was null. The overall median survival have been of 21 months, while surgical and chemotherapeutical median survival reached 32 months. The 5-year actuarial survival was: 10% (overall), 14% (treated patients), 50% (low grade), 33% (stage IE). With negative influence by istology and staging.
Divisione di Chirurgia Generale Andrea Ponti, Ospedale Ca Granda Niguarda, Milano.
P
P
Pradella
L
L
Maculotti
G
G
Sesana
D000206:Actuarial Analysis; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D005260:Female; D005743:Gastrectomy / Q000379:methods; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D012189:Retrospective Studies; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D016019:Survival Analysis; D016896:Treatment Outcome
Linfoma gastrico primitivo. 14 casi clinici.